EXCLUSIVE: FDA says ReShape Medical can skip advisory panel for obesity balloon device

The FDA lets San Clemente, Calif.-based ReShape Medical skip an advisory committee meeting for its obesity balloon device, CEO Richard Thompson tells MassDevice.com.

ReShape Medical

News Well, Food & Drug Administration (FDA), Gastrointestinal, Weight loss

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1IoCvIB